Memory test stations in pharmacies to spot early memory problems in older adults
Studies pharmacy memory tests for finding mild cognitive impairment or mild dementia in older people.
Key facts
- Who runs it
- Ludwig-Maximilians - University of Munich
- Where
- Germany1 site in 1 countryChoose a country to see its sites
- Trial code
- Registry title
- Dementia-friendly Apothecaries as a Resource for Mental Heath in the Elderly
- Status
- Recruiting
- People taking part
- 1,020 people, planned
- Started
- 1 Jul 2025
- Expected to end
- 31 Jul 2027
- Type of study
- Observational
- Record updated
- 1 April 2026
Who can take part
The trial is looking for people aged 60 or older with memory problems or mild thinking changes, noticed in pharmacies. They take a digital memory test at the pharmacy.
- Age
- 60 Years to 90 Years
- Sex
- All
- Disease stage
- Memory problems or mild thinking changes, noticed by the person, a relative or pharmacy staff.
- Main reasons for not taking part
- A past formal diagnosis of dementia
- Unable to see or hear well enough to do the digital tests or questionnaires
- Severe thinking or physical problems that prevent taking part in the tests
- Not enough German to understand the instructions
- Unable to give consent on your own
Show the full registry criteria (7)Hide the full registry criteria
Who can take part
- Age: Participants must be 60 years or older at the time of consent
- Language Proficiency: Sufficient knowledge of the German language to understand instructions and participate in the study
- Cognitive Status: Presence of self-reported, relative-reported, or pharmacist-identified cognitive impairments (e.g., memory problems or mild cognitive changes)
- Consent: Ability to provide informed consent voluntarily
Who cannot take part
- Previous Dementia Diagnosis: Individuals with a prior formal diagnosis of dementia, whether with or without underlying pathology
- Severe Cognitive or Physical Impairments: Any condition that would prevent meaningful participation in the digital tests or structured screening process; These criteria aim to ensure that the study includes participants at risk of early cognitive decline while excluding those for whom the interventions or assessments would not be feasible or relevant
- Severe Sensory Impairments: Participants unable to see or hear well enough to complete the digital assessments or questionnaires
Eligibility questionnaire
From the criteria published for this trial, to help you prepare for a talk with your doctor or the study team. We do not tell you a result. Only the study team can say whether you can take part.
- Age
- Mild cognitive impairment or mild dementia
This trial is currently available in Germany.
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
The DARE study (Dementia-Friendly Apothecaries as a Resource for Mental Health in the Elderly) is a multicenter, prospective cohort study aiming to identify individuals with cognitive impairments early in pharmacies and enhance their access to support services. Partner pharmacies are equipped with memory test stations, and pharmaceutical staff are trained to guide participants. The digital memory test evaluates cognitive, psychosocial, and health factors, displaying results in a traffic light graphic. Participants with concerning results are referred to specialists or support services.
Read full original descriptionShow less
The study's primary goals are to establish pharmacies as dementia screening hubs, improve care for affected individuals, promote interdisciplinary collaboration, and lay the groundwork for legal and billing frameworks. An optional subproject validates the screening through neurological evaluations.
The group in the trial
- prospective cohort study
The study cohort for the DARE project includes customers and patients from pharmacies located in both urban and rural areas. These participants represent a diverse population segment, including individuals who might not regularly access traditional healthcare services, particularly in rural regions where medical facilities are less accessible. Cohort Details: 1. Eligibility Criteria: * Age: 60 years and older. * Cognitive impairments noted by participants themselves, relatives, or pharmacy staff. * Sufficient understanding of the German language. 2. Inclusion Focus: * Individuals with early cognitive symptoms or mild dementia. * Those potentially underserved by conventional healthcare systems, such as isolated or single individuals.
Next steps
For your doctor
Doctor ask sheet
A PDF for your doctor: what this trial tests, who can take part, and 2 eligibility questions with room for answers and notes.
PDF, US Letter, 1 to 2 pages. A4 size
For the study team
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Demenz-freundliche Apotheken Als Ressource für Psychische Gesundheit im Alter
- Plain-language title
- Memory test stations in pharmacies to spot early memory problems in older adultsGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 15 November 2026.
- Criteria questions
- Built from NCT07504965, who can take part
- Record updated
- 1 April 2026